Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 3.613\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) Cn1cc(CCC(=O)N2CCCC(N3CCN(c4ccccc4F)CC3)C2)cn1
(b) COC(=O)COc1nsnc1N1CCOCC1
(c) COc1ccc(NC(=O)CSc2ncnc3c2nnn3-c2ccc(F)cc2)c(OC)c1
Answer: c. COc1ccc(NC(=O)CSc2ncnc3c2nnn3-c2ccc(F)cc2)c(OC)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)CSc2ncnc3c2nnn3-c2ccc(F)cc2)c(OC)c1
COc1ccc(NC(=O)CSc2ncnc3c2nnn3-c2ccc(F)cc2)c(OC)c1
N-(2,4-dimethoxyphenyl)-2-[3-(4-fluorophenyl)triazolo[4,5-d]pyrimidin-7-yl]sulfanylacetamide